[Hyperbaric treatment in the post-bronchitic emphysema].
Following some introductory mention of the physiology of hyperbaric oxygen therapy and some notes on the physiology of postbronchitic emphysema and its cardiac, hepatic, renal and neurological sequelae, a personal method of hyperbaric treatment is described. The results in the first 50 emphysematous patients submitted to this therapy are reported along with those of the examinations carried out to evaluate respiratory function, and changes in haematosis, and cardiac, hepatic, neurological and renal function. It is concluded that hyperbaric treatment of postbronchitic emphysema should be considered of choice for quick, effective resolution of alterations in haematosis and the organic sequelae deriving from respiratory insufficiency. In association with other therapy (antibiotics, anti-inflammatory and balsamic drugs) it is also capable of stopping or usefully delaying the disease's development.
D000469:Alkaline Phosphatase / Q000097:blood; D001991:Bronchitis / Q000150:complications*; D006801:Humans; D006931:Hyperbaric Oxygenation; D007931:Leucyl Aminopeptidase / Q000097:blood; D008448:Maximal Expiratory Flow Rate; D010101:Oxygen Consumption; D011656:Pulmonary Emphysema / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D000637:Transaminases / Q000097:blood; D014692:Ventilation-Perfusion Ratio
D000637:Transaminases; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase
La terapia iperbarica della malattia enfisematosa post-bronchitica